svg-arrow-next svg-arrow-prev
×

Order online: 0917-565-3700/ 0998-530-3700

sidebar

Lipanthyl NT 145mg 1 Tablet

(No reviews) Write a Review
₱61.50
  per tablet

SKU:
014800
Generic Name:
Fenofibrate


Note: Uploaded prescription slip is subject to validation by our Pharmacist.

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

Lipanthyl NT 145mg 1 Tablet

₱61.50

Lipanthyl NT 145mg 1 Tablet

₱61.50

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

IMPORTANT NOTICE:
For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription. Please present the original copy of your prescription upon the arrival of your order.

An item like loose capsule/tablets, ampules, vials, and refrigerated items is not subject for merchandise return or exchange upon completing the purchase.

Brand Name LIPANTHYL NT 145MG
Generic Name Fenofibrate
Strength 145mg Fenofibrate
Dosage Form Tablet
Class Name Antihypertriglyceredemia
Indication/Usage Indications:
Hypercholesterolemia and hypertriglyceridemia alone or combined (types IIa, IIb, IV dyslipidemias, as well as types III and V dyslipidemias) in patients unresponsive to dietary and other non-drug therapeutic measures (e.g. weight reduction or increased physical activity), particularly when there is evidence of associated risk such as hypertension and smoking.
The treatment of secondary hyperlipoproteinemias is indicated if the hyperlipoproteinemia persist despite effective treatment of the underlying disease (e.g. dyslipidemia in diabetes mellitus). Appropriate dietary measures initiated before therapy should be continued. Lipanthyl NT 145 mg is indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes.
 
Dosage and Administration The recommended dose is one tablet containing 145 mg fenofibrate taken once daily. Patients currently taking one 200 mg capsule (or one 160 mg tablet) can be changed to one 145 mg fenofibrate tablet without further dose adjustment.
Warning and Precautions Secondary cause of hyperlipidemia, such as uncontrolled type 2 diabetes
mellitus, hypothyroidism, nephrotic syndrome, dysproteinemia, obstructive
liver disease, pharmacological treatment, alcoholism, should be adequately
treated before fenofibrate therapy is considered.
Contraindication - Hepatic insufficiency (including biliary cirrhosis and unexplained persistent liver function abnormality)
- known gallbladder disease
- Severe chronic kidney disease
- Chronic or acute pancreatitis with exception of acute pancreatitis due to severe hypertriglyceridemia
- known photoallergy or phototoxic reaction during treatment with fibrates or ketoprofen
- Hypersensitivity to the active substances or to any of the excipients
Requires prescription? Yes
Storage Conditions Store at temperatures not exceeding 30°C, away from direct heat and sunlight
Manufacturer Fournier Laboratories Ireland Limited
Regulatory Classification Prescription Drug

Related Products

Be a member